Delpharm is a leading CDMO : - 19 plants in France, Italy, Canada, Poland and The Netherlands - Over 1,1 billion euros turnover - 6,500 people working in the company - Most dosage forms produced For over 35 years, Delpharm has built up its position by acquiring manufacturing plants over the years, in particular from big pharmaceutical companies. As multi-specialists, Delpharm is able to supply the majority of pharmaceutical forms available on the market, such as tablets and capsules, bottles and injectable ampoules, prefilled syringes, freeze-drying, suspensions, solutions, ointments and soft gel capsules. Delpharm also offers full development services for a wide range of pharmaceutical forms, chemical entities and innovative combinations, including the production of phase 1 to 3 clinical batches for solid, semi-solid, liquid and injectable forms.